KR910000102A - 효소형성 억제제 - Google Patents

효소형성 억제제 Download PDF

Info

Publication number
KR910000102A
KR910000102A KR1019890007598A KR890007598A KR910000102A KR 910000102 A KR910000102 A KR 910000102A KR 1019890007598 A KR1019890007598 A KR 1019890007598A KR 890007598 A KR890007598 A KR 890007598A KR 910000102 A KR910000102 A KR 910000102A
Authority
KR
South Korea
Prior art keywords
acid
agent
unsaturated fatty
medicament
agent according
Prior art date
Application number
KR1019890007598A
Other languages
English (en)
Inventor
유다까 미시마
야스유끼 오오야마
마사시 구리모도
Original Assignee
유다까 미시마
하야시바라 겡
가부시기가이샤 하야시바라 세이부쓰 가가꾸 겡뀨우죠
진나이 쓰네오
산쇼오 세이야꾸 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP13448288A external-priority patent/JPH01305026A/ja
Priority claimed from JP1222389A external-priority patent/JPH02193918A/ja
Application filed by 유다까 미시마, 하야시바라 겡, 가부시기가이샤 하야시바라 세이부쓰 가가꾸 겡뀨우죠, 진나이 쓰네오, 산쇼오 세이야꾸 가부시기가이샤 filed Critical 유다까 미시마
Publication of KR910000102A publication Critical patent/KR910000102A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

효소형성 억제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (15)

  1. 유효성분으로 포로피온산, 부티르산, 발레트산과 이들의 염 및 유도체에서 선택한 하나 또는 그 이상의 요소로 이루어짐을 특징으로 하는 티로시나제 형성을 자체에서 억제하는 약제.
  2. 제1항에 있어서, 프로피온산, 부리트산과 발레트산의 염이 프로피온산, 부티르산과 발레트산의 알카리금속염과 알카리 토금속염임을 특징으로 하는 약제.
  3. 제1항에 있어서, 프로피온산, 부티르산과 발레트산의 유도체가 프로피온산, 부티르산과 발레트산의 에스테르와 산아미드임을 특징으로 하는 약제.
  4. 제1항에 있어서, 약제가 주사제, 정제, 캡슐, 연고, 로우션 또는 밀크로우션임을 특징으로 하는 약제.
  5. 제1항에 있어서, 약제가 향장품임을 특징으로 하는 약제.
  6. 제5항에 있어서, 향장품이 주사제, 정제, 캡슐, 연고, 배드솔트, 로우션, 밀크로우션, 팩 또는 크리임을 특징으로 하는 약제.
  7. 제1항에 있어서, 약제의 투약량이 0.01-1.000g/일/성인임을 특징으로 하는 약제.
  8. 제1항에 있어서, 약제가 불포화 지방산과 이들의 염 및 유도체에서 선택한 하나 또는 그 이상의 요소를 부가적으로 함유함을 특징으로 하는 약제.
  9. 제8항에 있어서, 불포화 지방산이 12-22개의 탄소원자를 갖는 것임을 특징으로 하는 약제.
  10. 제9항에 있어서, 12-22개의 탄소원자를 갖는 불포화 지방산이 라우토레산, 미리스톨레산, 펜타데세노산, 시스-9-헥사데세노산, 올레산, 리놀레산, 리놀렌산, 가돌레산, 아라키돈산, 4,8,12,16-아이코사테트라에노산, 5,8,11,14,17-아이코사펜타에노산, 에루크산과 클루파노돈산임을 특징으로 하는 약제.
  11. 제8항에 있어서, 불포화 지방산의 염이 불포화 지방산의 염이 불포화 지방산의 알카리 금속염과 알칼리토류 금속염임을 특징으로 하는 약제.
  12. 제8항에 있어서, 불포화 지방산의 유도체가 불포화 지방산의 에스테르와 산아미드임을 특징으로 하는 약제.
  13. 제8항에 있어서, 약제가 향장품임을 특징으로 하는 약제.
  14. 제13항에 있어서, 향장품이 주사제, 정제, 캡슐, 연고, 배드솔트, 로우션, 밀크로우션, 팩 또는 크리임을 특징으로 하는 약제.
  15. 제8항에 있어서, 약제의 투약량이 0.01-500g/일/성인임을 특징으로 하는 약제.
    ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890007598A 1988-06-02 1989-06-02 효소형성 억제제 KR910000102A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP88-134482 1988-06-02
JP13448288A JPH01305026A (ja) 1988-06-02 1988-06-02 酵素生成抑制剤
JP89-12223 1989-01-21
JP1222389A JPH02193918A (ja) 1989-01-21 1989-01-21 酵素生成抑制剤

Publications (1)

Publication Number Publication Date
KR910000102A true KR910000102A (ko) 1991-01-29

Family

ID=26347796

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890007598A KR910000102A (ko) 1988-06-02 1989-06-02 효소형성 억제제

Country Status (2)

Country Link
EP (1) EP0345081A3 (ko)
KR (1) KR910000102A (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2780989B2 (ja) * 1989-01-28 1998-07-30 三省製薬株式会社 外用剤
DE4042437A1 (de) * 1990-07-18 1992-06-11 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer verbrennungen
GB9118028D0 (en) * 1991-08-21 1991-10-09 Secr Defence Brit Improved transdrmal formulations
US5874463A (en) 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
AR017859A1 (es) * 1997-12-15 2001-10-24 Unilever Nv Una composicion cosmetica para aclarar la piel, de aplicacion topica sobre la piel humana y un metodo cosmetico para aclarar la piel que comprende la aplicacion topica sobre la misma de dicha composicion
WO2001078704A2 (en) * 2000-04-13 2001-10-25 Evans William T Gaba substrate and the use thereof for treating cognitive and emotional disorders
FR2822701B1 (fr) * 2001-04-03 2005-03-18 Lvmh Rech Utilisation d'un extrait d'algue phaeodactylum comme agent cosmetique favorisant l'activite du proteasome des cellules de la peau et composition cosmetique le contenant
FR2858932B1 (fr) * 2003-08-22 2009-10-30 Oreal Composition destinee a lutter contre la degradation des fibres de collagene induite en condition d'exposition solaire naturelle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH566780A5 (ko) * 1970-06-24 1975-09-30 Bristol Myers Co
IT1075741B (it) * 1977-04-19 1985-04-22 Porro Marcella Composizione per il trattamento di dermatosi iperpigmentarie
JPS567710A (en) * 1979-06-28 1981-01-27 Sansho Seiyaku Kk Whitening cosmetic
JPH064529B2 (ja) * 1985-03-20 1994-01-19 株式会社資生堂 皮膚外用剤
JPS63284109A (ja) * 1987-05-15 1988-11-21 Sunstar Inc 美白化粧料

Also Published As

Publication number Publication date
EP0345081A2 (en) 1989-12-06
EP0345081A3 (en) 1990-03-28

Similar Documents

Publication Publication Date Title
KR910000101A (ko) 효소형성 억제제
KR910005847A (ko) 피부 백색제
RU94045141A (ru) Гетероциклические производные карбоновой кислоты и их соли и фармацевтическая композиция с антифибротической или тормозящей пролилгидроксилазу или биосинтез коллагена активностью
NZ217703A (en) 2-(2-fluoro-4-biphenylyl) propionic acid compositions
ATE386508T1 (de) Feste orale dosierungsform enthaltend einen resorptionsverstärker
ATE171341T1 (de) Pestizide zusammensetzungen auf der basis von salzen der fettsäuren
KR940018090A (ko) 트리글리세라이드
AU3443200A (en) Compositions containing boswellia extracts
NO176082C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel
KR910000102A (ko) 효소형성 억제제
KR880011139A (ko) 크로몬 유도체
KR900011470A (ko) 외용제
GB1097531A (en) Improvements in or relating to the preparation of cyclopentane derivatives
GB1395666A (en) Thiophene derivatives processes for their preparation and compositions incorporating them
TW360545B (en) Dermatologic preparation
GB1514389A (en) Glycerides with antibacterial properties
KR970706828A (ko) 경피 투여형 제제(percutaneously administrable preparation)
DE3884508D1 (de) Cystein-derivate mit expectorans-wirkung.
MX9203292A (es) Derivados de acidos grasos omega-3 poliinsaturados, su preparacion y aplicacion
IE34275B1 (en) Alpha-hydrazino acids
KR950702412A (ko) 항 hiv제
GB905197A (en) Anti-viral compositions comprising 1-phenyl-2-amino-propane-1,3-diol derivatives
JPS5248666A (en) Preparation of mercaptothiazole-carboxylic acids and their esters
JPS5441821A (en) 2-(3-alkylnitrosoureido)glucopyranoside derivative
SE8802243D0 (sv) Farmaceutisk beredning

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid